Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making

Purpose of reviewEmerging data suggest that biomarkers of brain injury have potential utility as diagnostic, prognostic, and therapeutic adjuncts in the setting of traumatic and ischemic brain injury. Two approaches are being used, namely, assessing markers of structural damage and quantifying mediators of the cellular, biochemical, or molecular cascades in secondary injury or repair. Novel proteomic, multiplex, and lipidomic methods are also being applied. Recent findingsBiochemical markers of neuronal, glial, and axonal damage such as neuron-specific enolase, S100B, and myelin basic protein, respectively, are readily detectable in biological samples such as serum or cerebrospinal fluid and are being studied in patients with ischemic and traumatic brain injury. In addition, a number of studies have demonstrated that novel tools to assess simultaneously multiple biomarkers can provide unique insight such as details on specific molecular participants in cell death cascades, inflammation, or oxidative stress. SummaryMultifaceted cellular, biochemical, and molecular monitoring of proteins and lipids is logical as an adjunct to guiding therapies and improving outcomes in traumatic and ischemic brain injury and we appear to be on the verge of a breakthrough with the use of these markers as diagnostic, prognostic, and monitoring adjuncts, in neurointensive care.

[1]  M. Kreuter,et al.  Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. , 2001, Blood.

[2]  S. Wisniewski,et al.  Cytochrome c, a Biomarker of Apoptosis, is Increased in Cerebrospinal Fluid from Infants with Inflicted Brain Injury from Child Abuse , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Simon C Watkins,et al.  Increases in Bcl‐2 and cleavage of caspase‐1 and caspase‐3 in human brain after head injury , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  P. Sojka,et al.  Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game , 2006, British Journal of Sports Medicine.

[5]  P. Kochanek,et al.  Identification of Inflicted Traumatic Brain Injury in Well-Appearing Infants Using Serum and Cerebrospinal Markers: A Possible Screening Tool , 2006, Pediatrics.

[6]  P. Kochanek,et al.  Increased Phosphorylation of Protein Kinase B and Related Substrates after Traumatic Brain Injury in Humans and Rats , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  C. Alling,et al.  Controversial significance of early S100B levels after cardiac surgery , 2004, BMC neurology.

[8]  R. Wells,et al.  Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[9]  D. Marion,et al.  Increased transmitter amino acid concentration in human ventricular CSF after brain trauma , 1994, Neuroreport.

[10]  S. Wisniewski,et al.  Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. , 2002, Pediatrics.

[11]  P. Kochanek,et al.  Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. , 2002, Journal of neurotrauma.

[12]  M. Skalej,et al.  Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke , 2006, Clinical Neurology and Neurosurgery.

[13]  Increased levels of serum S100B protein in critically ill patients without brain injury , 2005, Shock.

[14]  C. McClain,et al.  Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. , 1991, The Journal of laboratory and clinical medicine.

[15]  E. Faist,et al.  The impact of endogenous triggers on trauma-associated inflammation , 2006, Current opinion in critical care.

[16]  H. Steinmetz,et al.  Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. , 2007, Stroke.

[17]  S. Beers,et al.  Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. , 2007, Journal of neurotrauma.

[18]  Sara E. Miller,et al.  Proteomics of cerebral injury in a neonatal model of cardiopulmonary bypass with deep hypothermic circulatory arrest. , 2006, The Journal of thoracic and cardiovascular surgery.

[19]  R. Sapolsky,et al.  Biphasic Cytochrome c Release After Transient Global Ischemia and its Inhibition by Hypothermia , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  A. Raabe,et al.  GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. , 2004, Journal of neurotrauma.

[21]  K. Fox,et al.  Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100 , 2007, Heart.

[22]  J. Hutchison,et al.  Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. , 2007, Journal of neurotrauma.

[23]  Rosa Viner,et al.  Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis , 2007, Annals of neurology.

[24]  S. Wisniewski,et al.  The Th1 versus Th2 cytokine profile in cerebrospinal fluid after severe traumatic brain injury in infants and children , 2001, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[25]  R. Tufano,et al.  S100B Is Not a Reliable Prognostic Index in Paediatric TBI , 2007, Pediatric Neurosurgery.

[26]  S. Wisniewski,et al.  Increased adrenomedullin in cerebrospinal fluid after traumatic brain injury in infants and children. , 2001, Journal of neurotrauma.

[27]  S. Wisniewski,et al.  Increases in bcl-2 protein in cerebrospinal fluid and evidence for programmed cell death in infants and children after severe traumatic brain injury. , 2000, The Journal of pediatrics.

[28]  S. Kelsey,et al.  Brain Enzyme Levels in CSF after Cardiac Arrest and Resuscitation in Dogs: Markers of Damage and Predictors of Outcome , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  J. Broderick,et al.  Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study , 2006, Stroke.

[30]  S. Wisniewski,et al.  Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. , 2004, Journal of neurotrauma.

[31]  P. Kochanek,et al.  Urinary S100B concentrations are increased after brain injury in children: A preliminary study* , 2006, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[32]  Thomas Brott,et al.  The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. , 2005, Annals of emergency medicine.

[33]  P. Kochanek,et al.  Biochemical, cellular, and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: Lessons learned from the bedside , 2000, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[34]  C. Robertson,et al.  Clinical Significance of αII-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury , 2007 .

[35]  K. Hossmann.  Viability thresholds and the penumbra of focal ischemia , 1994, Annals of neurology.

[36]  P. E. Kunkler,et al.  Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue , 2004, Journal of Neuroscience Methods.

[37]  V. Selaković,et al.  The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction , 2005, Journal of Clinical Neuroscience.

[38]  P. Kochanek,et al.  Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. , 2005, Journal of neurosurgery.

[39]  F. Tortella,et al.  Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats* , 2006, Molecular & Cellular Proteomics.

[40]  W. Dietrich,et al.  The effect of therapeutic hypothermia on the expression of inflammatory response genes following moderate traumatic brain injury in the rat. , 2005, Brain research. Molecular brain research.

[41]  K. Waterloo,et al.  S100B serum level predicts computed tomography findings after minor head injury. , 2007, The Journal of trauma.

[42]  J. Auer,et al.  Ability of neuron-specific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitation. , 2006, CJEM.

[43]  M. Kutner,et al.  Concentration of 3', 5' cyclic adenosine monophosphate in ventricular cerebrospinal fluid of patients with prolonged coma after head trauma or intracranial hemorrhage. , 1976, The New England journal of medicine.

[44]  R. Clark,et al.  Gel-Based Hippocampal Proteomic Analysis 2 Weeks following Traumatic Brain Injury to Immature Rats Using Controlled Cortical Impact , 2006, Developmental Neuroscience.

[45]  M. Fujimura,et al.  Release of mitochondrial cytochrome c and DNA fragmentation after cold injury-induced brain trauma in mice: possible role in neuronal apoptosis , 1999, Neuroscience Letters.

[46]  J. Hutchison,et al.  Protein Biomarkers in Serum of Pediatric Patients with Severe Traumatic Brain Injury Identified by ICAT–LC-MS/MS , 2007 .

[47]  P. Kochanek,et al.  Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. , 1997, Neurosurgery.

[48]  Simon C Watkins,et al.  Caspase‐8 expression and proteolysis in human brain after severe head injury , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  S. Wisniewski,et al.  Interleukin‐8 is increased in cerebrospinal fluid of children with severe head injury , 2000, Critical care medicine.

[50]  W. Mauritz,et al.  NONSPECIFIC INCREASE OF SYSTEMIC NEURON-SPECIFIC ENOLASE AFTER TRAUMA: CLINICAL AND EXPERIMENTAL FINDINGS , 2005, Shock.

[51]  S. Wisniewski,et al.  Serum S100B concentrations are increased after closed head injury in children: a preliminary study. , 2002, Journal of neurotrauma.

[52]  P. Safar,et al.  The use of cytosolic enzyme increase in cerebrospinal fluid of patients resuscitated after cardiac arrest , 1994 .

[53]  D. McArthur,et al.  S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome , 2006, Journal of Clinical Neuroscience.

[54]  T. Leino,et al.  Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. , 2004, The Journal of trauma.

[55]  L. Mascia,et al.  Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. , 1998, Acta neurochirurgica. Supplement.

[56]  P. Kochanek,et al.  Serum Biomarkers after Traumatic and Hypoxemic Brain Injuries: Insight into the Biochemical Response of the Pediatric Brain to Inflicted Brain Injury , 2006, Developmental Neuroscience.

[57]  R. Vemuganti,et al.  Putative endogenous mediators of preconditioning‐induced ischemic tolerance in rat brain identified by genomic and proteomic analysis , 2004, Journal of neurochemistry.

[58]  R. Tufano,et al.  S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest. , 2005, Minerva chirurgica.

[59]  D. Cohen,et al.  Ventricular fluid interleukin-1 activity in patients with head injury. , 1987, The Journal of laboratory and clinical medicine.

[60]  H. Redl,et al.  NEURON-SPECIFIC-ENOLASE IS INCREASED IN PLASMA AFTER HEMORRHAGIC SHOCK AND AFTER BILATERAL FEMUR FRACTURE WITHOUT TRAUMATIC BRAIN INJURY IN THE RAT , 2004, Shock.

[61]  P. Kochanek,et al.  Assessment of Antioxidant Reserves and Oxidative Stress in Cerebrospinal Fluid after Severe Traumatic Brain Injury in Infants and Children , 2002, Pediatric Research.

[62]  S. Wisniewski,et al.  Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. , 1997, Journal of neurotrauma.

[63]  S. Wisniewski,et al.  Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. , 2007, Journal of neurotrauma.

[64]  K. Kibayashi,et al.  Changes in localization of synaptophysin following fluid percussion injury in the rat brain , 2006, Brain Research.

[65]  E. Tremoli,et al.  Acute-Phase Proteins Before Cerebral Ischemia in Stroke-Prone Rats: Identification by Proteomics , 2001, Stroke.

[66]  P. Kochanek,et al.  Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. , 2004, Journal of neurotrauma.